Nano-drug delivery systems based on biodegradable polymers for the therapy of gynecological malignancies

被引:2
作者
Jin, Keer [1 ]
Zhang, Hanxue [1 ]
Yang, Yuwei [1 ]
Gao, Yan [1 ]
机构
[1] China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Dept Gynecol, Shenyang, Peoples R China
关键词
Biodegradable polymers; drug-delivery system; gynecological malignancy; nanoparticles; ANTIOVARIAN CANCER ACTIVITY; OVARIAN-CANCER; PLGA NANOPARTICLES; CERVICAL-CANCER; CO-DELIVERY; MPEG-PLA; PACLITAXEL; MICELLES; DOCETAXEL; PROGRESS;
D O I
10.1080/00914037.2023.2263133
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Gynecological malignancies are the main factors that seriously endanger the life and health of women worldwide. Chemotherapy is one of the traditional methods for the treatment of gynecological malignancies. Conventional chemotherapeutic drugs used in medicine have shortcomings, such as poor target tissue-specific distribution, high toxicity, and side effects. They are prone to problems such as tumor recurrence, invasion, metastasis, and drug resistance. The rapid development of nano-drug delivery systems achieves attenuation, potentiation, inhibition of metastasis, and resistance to drug resistance, bringing hope for the treatment of gynecological malignancies. This article briefly summarizes novel nano-drug delivery systems based on biodegradable polymers and their mediated treatment strategy for gynecological tumors to provide a theoretical basis for developing and clinically translating nano-drug delivery systems for gynecological malignancies. [GRAPHICS] .
引用
收藏
页码:1262 / 1277
页数:16
相关论文
共 95 条
  • [1] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
    Arbyn, Marc
    Weiderpass, Elisabete
    Bruni, Laia
    de Sanjose, Silvia
    Saraiya, Mona
    Ferlay, Jacques
    Bray, Freddie
    [J]. LANCET GLOBAL HEALTH, 2020, 8 (02): : E191 - E203
  • [2] Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy
    Avramovic, Natasa
    Mandic, Boris
    Savic-Radojevic, Ana
    Simic, Tatjana
    [J]. PHARMACEUTICS, 2020, 12 (04)
  • [3] Barenholz Y., 2021, Handbook of Harnessing Biomaterials in Nanomedicine, P463, DOI DOI 10.1201/9781003125259-16
  • [4] RGD Peptide-Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances
    Battistini, Lucia
    Bugatti, Kelly
    Sartori, Andrea
    Curti, Claudio
    Zanardi, Franca
    [J]. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2021, 2021 (17) : 2506 - 2528
  • [5] Molybdenum cluster loaded PLGA nanoparticles: An innovative theranostic approach for the treatment of ovarian cancer
    Brandhonneur, N.
    Hatahet, T.
    Amela-Cortes, M.
    Molard, Y.
    Cordier, S.
    Dollo, G.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 125 : 95 - 105
  • [6] Endometrial cancer: mapping the global landscape of research
    Brueggmann, Doerthe
    Ouassou, Katja
    Klingelhoefer, Doris
    Bohlmann, Michael K.
    Jaque, Jenny
    Groneberg, David A.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [7] RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics
    Cheng, Yu
    Ji, Yuanhui
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 128 : 8 - 17
  • [8] Nanomaterials for cancer therapy: current progress and perspectives
    Cheng, Zhe
    Li, Maoyu
    Dey, Raja
    Chen, Yongheng
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [9] Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer
    Cho, Hyunah
    Lai, Tsz Chung
    Kwon, Glen S.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2013, 166 (01) : 1 - 9
  • [10] International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
    Coburn, S. B.
    Bray, F.
    Sherman, M. E.
    Trabert, B.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) : 2451 - 2460